These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30857461)

  • 1. Unusual Presentation of PMM2-Congenital Disorder of Glycosylation With Isolated Strokelike Episodes in a Young Girl.
    Farmania R; Jain P; Sharma S; Aneja S
    J Child Neurol; 2019 Jun; 34(7):410-414. PubMed ID: 30857461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial diagnosis of the congenital disorder of glycosylation PMM2-CDG (CDG1a) in a 4-year-old girl after neurosurgical intervention for cerebral hemorrhage.
    Stefanits H; Konstantopoulou V; Kuess M; Milenkovic I; Matula C
    J Neurosurg Pediatr; 2014 Nov; 14(5):546-9. PubMed ID: 25192236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG).
    Martínez-Monseny AF; Bolasell M; Callejón-Póo L; Cuadras D; Freniche V; Itzep DC; Gassiot S; Arango P; Casas-Alba D; de la Morena E; Corral J; Montero R; Pérez-Cerdá C; Pérez B; Artuch R; Jaeken J; Serrano M;
    Ann Neurol; 2019 May; 85(5):740-751. PubMed ID: 30873657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling.
    Drouin-Garraud V; Belgrand M; Grünewald S; Seta N; Dacher JN; Hénocq A; Matthijs G; Cormier-Daire V; Frébourg T; Saugier-Veber P
    Am J Med Genet; 2001 Jun; 101(1):46-9. PubMed ID: 11343337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
    Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
    Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy.
    Izquierdo-Serra M; Martínez-Monseny AF; López L; Carrillo-García J; Edo A; Ortigoza-Escobar JD; García Ó; Cancho-Candela R; Carrasco-Marina ML; Gutiérrez-Solana LG; Cuadras D; Muchart J; Montero R; Artuch R; Pérez-Cerdá C; Pérez B; Pérez-Dueñas B; Macaya A; Fernández-Fernández JM; Serrano M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29470411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
    Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
    Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up.
    Altassan R; Péanne R; Jaeken J; Barone R; Bidet M; Borgel D; Brasil S; Cassiman D; Cechova A; Coman D; Corral J; Correia J; de la Morena-Barrio ME; de Lonlay P; Dos Reis V; Ferreira CR; Fiumara A; Francisco R; Freeze H; Funke S; Gardeitchik T; Gert M; Girad M; Giros M; Grünewald S; Hernández-Caselles T; Honzik T; Hutter M; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-de-Silva D; Martinez AF; Moravej H; Õunap K; Pascoal C; Pascreau T; Patterson M; Quelhas D; Raymond K; Sarkhail P; Schiff M; Seroczyńska M; Serrano M; Seta N; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Witters P; Zeevaert R; Morava E
    J Inherit Metab Dis; 2019 Jan; 42(1):5-28. PubMed ID: 30740725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital disorders of glycosylation with neonatal presentation.
    Resende C; Carvalho C; Alegria A; Oliveira D; Quelhas D; Bandeira A; Proença E
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24739649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.
    Serrano M; de Diego V; Muchart J; Cuadras D; Felipe A; Macaya A; Velázquez R; Poo MP; Fons C; O'Callaghan MM; García-Cazorla A; Boix C; Robles B; Carratalá F; Girós M; Briones P; Gort L; Artuch R; Pérez-Cerdá C; Jaeken J; Pérez B; Pérez-Dueñas B
    Orphanet J Rare Dis; 2015 Oct; 10():138. PubMed ID: 26502900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From gestalt to gene: early predictive dysmorphic features of PMM2-CDG.
    Martinez-Monseny A; Cuadras D; Bolasell M; Muchart J; Arjona C; Borregan M; Algrabli A; Montero R; Artuch R; Velázquez-Fragua R; Macaya A; Pérez-Cerdá C; Pérez-Dueñas B; Pérez B; Serrano M;
    J Med Genet; 2019 Apr; 56(4):236-245. PubMed ID: 30464053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PMM2-CDG caused by an A108V mutation associated with a heterozygous 70 kilobases deletion case report.
    Lebredonchel E; Riquet A; Neut D; Broly F; Matthijs G; Klein A; Foulquier F
    Ital J Pediatr; 2022 Oct; 48(1):178. PubMed ID: 36221102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions.
    Muthusamy K; Perez-Ortiz JM; Ligezka AN; Altassan R; Johnsen C; Schultz MJ; Patterson MC; Morava E
    Genet Med; 2024 Feb; 26(2):101027. PubMed ID: 37955240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorbitol Is a Severity Biomarker for PMM2-CDG with Therapeutic Implications.
    Ligezka AN; Radenkovic S; Saraswat M; Garapati K; Ranatunga W; Krzysciak W; Yanaihara H; Preston G; Brucker W; McGovern RM; Reid JM; Cassiman D; Muthusamy K; Johnsen C; Mercimek-Andrews S; Larson A; Lam C; Edmondson AC; Ghesquière B; Witters P; Raymond K; Oglesbee D; Pandey A; Perlstein EO; Kozicz T; Morava E
    Ann Neurol; 2021 Dec; 90(6):887-900. PubMed ID: 34652821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycomic Characterization of Induced Pluripotent Stem Cells Derived from a Patient Suffering from Phosphomannomutase 2 Congenital Disorder of Glycosylation (PMM2-CDG).
    Thiesler CT; Cajic S; Hoffmann D; Thiel C; van Diepen L; Hennig R; Sgodda M; Weiβmann R; Reichl U; Steinemann D; Diekmann U; Huber NM; Oberbeck A; Cantz T; Kuss AW; Körner C; Schambach A; Rapp E; Buettner FF
    Mol Cell Proteomics; 2016 Apr; 15(4):1435-52. PubMed ID: 26785728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline mental development in a congenital disorder of glycosylation (CDG) type Ia patient with multisystemic involvement (intermediate phenotype).
    Barone R; Sturiale L; Fiumara A; Uziel G; Garozzo D; Jaeken J
    J Inherit Metab Dis; 2007 Feb; 30(1):107. PubMed ID: 17186415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.
    Kjaergaard S; Schwartz M; Skovby F
    Arch Dis Child; 2001 Sep; 85(3):236-9. PubMed ID: 11517108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG).
    Taday R; Grüneberg M; DuChesne I; Reunert J; Marquardt T
    Orphanet J Rare Dis; 2020 Sep; 15(1):258. PubMed ID: 32962735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Child Neurology: a case of PMM2-CDG (CDG 1a) presenting with unusual eye movements.
    Coorg R; Lotze TE
    Neurology; 2012 Oct; 79(15):e131-3. PubMed ID: 23045520
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous fat pads on body MRI--an early sign of congenital disorder of glycosylation PMM2-CDG (CDG1a).
    Al-Maawali AA; Miller E; Schulze A; Yoon G; Blaser SI
    Pediatr Radiol; 2014 Feb; 44(2):222-5. PubMed ID: 24037084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.